Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - CHANGE IN WORKING CAPITAL
Change in Working Capital RARE - Ultragenyx Pharmaceutical Inc.
-15.1 M
LAST VALUE
51.13%
2 YEAR CAGR
9.44%
5 YEAR CAGR
-25.61%
10 YEAR CAGR